Krystal Biotech Inc (KRYS): Next-Year EPS Estimate 25.28%
As of 2026-06-04, Krystal Biotech Inc (KRYS) has a next-year EPS growth estimate of 25.28%.
On 2026-05-05, analyst consensus for KRYS's next-year EPS growth shifted from 25.74% to 25.28% — a negative change of 0.46 percentage points. The revised estimate has been sustained across 23 subsequent trading sessions. Current-year growth is projected at 13.33%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 25.28%
- EPS growth this year
- 13.33%
- EPS next quarter (est)
- $1.79
- Last price
- $307.79
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 25.28% | 13.33% | $1.79 | $307.79 |
| 2026-06-03 | 25.28% | 13.33% | $1.79 | $301.82 |
| 2026-06-02 | 25.28% | 13.33% | $1.79 | $293.21 |
| 2026-06-01 | 25.28% | 13.33% | $1.79 | $298.10 |
| 2026-05-31 | 25.28% | 13.33% | $1.79 | $309.03 |
| 2026-05-28 | 25.28% | 13.33% | $1.79 | $310.30 |
| 2026-05-27 | 25.28% | 13.33% | $1.79 | $306.63 |
| 2026-05-26 | 25.28% | 13.33% | $1.79 | $302.68 |
| 2026-05-25 | 25.28% | 13.33% | $1.79 | $299.45 |
| 2026-05-24 | 25.28% | 13.33% | $1.79 | $299.45 |
| 2026-05-21 | 25.28% | 13.33% | $1.79 | $304.23 |
| 2026-05-20 | 25.28% | 13.33% | $1.79 | $302.05 |
| 2026-05-19 | 25.28% | 13.33% | $1.79 | $293.30 |
| 2026-05-18 | 25.28% | 13.33% | $1.79 | $291.75 |
| 2026-05-17 | 25.28% | 13.33% | $1.79 | $306.29 |
| 2026-05-14 | 25.28% | 13.33% | $1.79 | $316.30 |
| 2026-05-13 | 25.28% | 13.33% | $1.79 | $316.57 |
| 2026-05-12 | 25.28% | 13.33% | $1.79 | $310.31 |
| 2026-05-11 | 25.28% | 13.33% | $1.79 | $312.88 |
| 2026-05-10 | 25.28% | 13.33% | $1.79 | $305.71 |
| 2026-05-07 | 25.28% | 13.33% | $1.79 | $296.70 |
| 2026-05-06 | 25.28% | 13.33% | $1.79 | $288.99 |
| 2026-05-05 | 25.28% | 13.33% | $1.79 | $284.57 |
| 2026-05-04 | 25.74% | 11.72% | $1.73 | $276.94 |
| 2026-04-23 | 26.61% | 11.69% | $1.50 | $277.69 |
| 2026-04-22 | 26.61% | 11.69% | $1.50 | $275.94 |
| 2026-04-21 | 26.61% | 11.69% | $1.50 | $272.66 |
| 2026-04-20 | 26.61% | 11.69% | $1.50 | $276.50 |
| 2026-04-19 | 27.94% | 10.53% | $1.49 | $274.21 |
| 2026-04-16 | 27.94% | 10.53% | $1.49 | $264.06 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Krystal Biotech Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Krystal Biotech Inc (KRYS) has a next-year EPS growth estimate of 25.28%, based on analyst consensus.
When was the latest EPS estimate revision for KRYS?▾
The most recent revision occurred on 2026-05-05, when analysts adjusted the next-year EPS growth estimate from 25.74% to 25.28%.
What sector and industry does Krystal Biotech Inc belong to?▾
Krystal Biotech Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. KRYS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Krystal Biotech Inc (KRYS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports